Clinical trials
Quadriplegia trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 8 |
| 2019 | 6 |
| 2020 | 1 |
| 2021 | 9 |
| 2022 | 7 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Recruiting | 28 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 2 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| VA Office of Research and Development | 6 |
| Leigh R. Hochberg, MD, PhD. | 4 |
| Shepherd Center, Atlanta GA | 4 |
| Johns Hopkins University | 3 |
| MetroHealth Medical Center | 3 |
| Neuralink Corp | 3 |
| Richard A. Andersen, PhD | 3 |
| University of Miami | 3 |
| University of Pittsburgh | 3 |
| Virginia Commonwealth University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Quadriplegia | 80 |
| Spinal Cord Injuries | 64 |
| Paraplegia | 24 |
| Paralysis | 20 |
| Amyotrophic Lateral Sclerosis | 13 |
| Brain Stem Infarctions | 10 |
| Muscular Dystrophies | 7 |
| Stroke | 7 |
| Dysarthria | 4 |
| Locked-In Syndrome | 4 |
Trials
Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.